AKARI THERAPEUTICS PLC-ADR (AKTX) Earnings History & Surprises

NASDAQ:AKTX • US00972G2075

0.2512 USD
+0 (+1.87%)
At close: Mar 6, 2026
0.249 USD
0 (-0.88%)
After Hours: 3/6/2026, 8:00:22 PM

Past quarterly earnings results for AKARI THERAPEUTICS PLC-ADR (AKTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateApr 13, 2026
PeriodQ4 / 2025
EPS Estimate-$0.04
Revenue Estimate

Last Reported

Most Recent
Release DateNov 13, 2025
PeriodQ3 / 2025
EPS Reported$0.00
EPS Surprise 100.00%
Revenue Surprise %

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 0.00 -0.08 100.00% 100.00% - -
Q2 2025 0.00 -0.12 100.00% 100.00% - -
Q1 2025 - - - -
Q4 2024 -1.02 - - - -
Q3 2024 -0.61 - - - -
Q2 2024 -1.02 - - - -
Q1 2024 -1.02 - 16.67% - -
Q4 2023 -1.02 - 28.57% - -
Q3 2023 -0.61 - 25.00% - -
Q2 2023 -1.02 - -920.00% - -
Q1 2023 -1.22 - - - -
Q4 2022 -1.43 - - - -
Q3 2022 -0.82 - - - -
Q2 2022 -0.10 - 9.09% - -
Q1 2022 0.00 - - - -
Q4 2021 0.00 - - - -
Q3 2021 0.00 0.00 - - - -
Q2 2021 -0.11 0.00 - - - -
Q1 2021 0.00 0.00 - 100.00% - -
Q4 2020 0.00 - - - -
Q3 2020 0.00 - - - -
Q2 2020 0.00 - - - -
Q1 2020 -2.60 0.00 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AKTX EPS Q2Q GrowthAKTX EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/22 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q2/25 Q3/25 Q4/25 Q4/26 0 -200 -400 -600 -800

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

AKARI THERAPEUTICS PLC-ADR / AKTX Earnings FAQ

When did AKARI THERAPEUTICS PLC-ADR (AKTX) report earnings last quarter?

AKARI THERAPEUTICS PLC-ADR (AKTX) last reported earnings on 11/13/2025.


Can you provide information on whether AKARI THERAPEUTICS PLC-ADR beat earnings estimates in the last quarter?

AKARI THERAPEUTICS PLC-ADR (AKTX) beat EPS estimates and missed revenue estimates in the most recent quarter.